Christopher Moxham - Chief Scientific Officer at Fulcrum Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer
Stock Symbol
FULC on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Christopher Moxham since 12/22/2023

Holdings reported by Christopher Moxham for Fulcrum Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 31.1K $103K $3.31 Aug 10, 2021 Direct
Stock Option (right to buy) 72.5K Aug 10, 2021 Direct Common Stock
Common Stockm 0 $18.00 Aug 10, 2021 Direct

Transactions reported by Christopher Moxham for Fulcrum Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.